Stop Invisible Aggregates Before They Destroy Your Gene Therapy
The complexity of lentiviral vectors (LVVs) presents many challenges when it comes to gene therapy manufacturing.
Compared to protein biologics, LVVs can be more difficult and expensive to manufacture. The scarcity of LVV material also makes scale-up difficult and adds additional complexity when qualifying subvisible particles, the most indicative critical quality attribute for lentivirus stability.
What if there was a way to overcome these challenges?
With Aura GT, there is.
Why Use Aura to Measure Lentivirus Stability?
Because you can achieve so much more insight with much less material:
- Achieve more accurate results with minimal amounts of sample (as little as 5 μL per test)
- Identify SYBR™-labeled nucleic aggregates from unstable viral vectors
- Detect and quantitate particles not measured by DLS or SEC
- Determine root cause for unstable gene therapies
- 96-well format for high-throughput testing
- Gather comprehensive data and insight into aggregate particles – size, morphology, counts, distribution
- Get insights quickly with rapid analysis time of 1 minute per sample
- Benefit from a wide working range: measure particles from 1 μm to 5 mm with high reproducibility
- Analyze particles without the interference of buffer or matrix for higher sensitivity
- 21 CFR Part 11 software available
Three commercial LVV products exhibiting highly varying levels of stability.
A Better Way to Tackle Lentiviral Stability
With Aura GT, you can quickly identify the most promising lentivirus candidates for late-stage discovery with just 5 μL of material.
Aura GT employs Backgrounded Membrane Imaging (BMI), a modern form of membrane microscopy that yields quick and accurate results, allowing you to quantify visible and subvisible particles in under 1 minute per sample.
Now you get a comprehensive picture—from images and counts to size distributions and identities. Whether you’re using LVV as starting material for cell and gene therapies or directly as APIs, you can be assured of lentivirus stability throughout the development pipeline.
FMM analysis of samples: Sample was stained with SYBR gold. (a) Whole well FMM image – white represents fluorescence signal, (b) SYBR Gold fluorescence intensity (Y-axis, relative fluorescent units) vs. size (X-axis, ECD, microns) showing a significant presence of nucleic acid.
Get to the Root of Your Lentiviral Vector Aggregation and Instability
Using commercially available dyes like SYBR Gold, Aura GT makes it easy to learn more about the nature of these large lentiviral aggregates.
Fluorescence Membrane Microscopy (FMM) builds upon Aura’s BMI technology to identify biological and chemical makeup. Particle Vue software takes it a step further, delivering characterization and quantification capabilities that enable scientists to get to the root cause of lentiviral aggregation and instability issues.
Featured products
Aura+
With the ability to support the full range of development and manufacturing applications across therapeutic approaches—including protein/antibody therapeutics, gene therapies, cell therapies, and small molecules—Aura+ packs powerful flexibility into a single particle analyzer.
Features
- 5 µL to 10 mL volume
- Particle characterization for protein, cell and gene therapeutics
- Three fluorescent channels for particle identification
- 4x and 20x magnification imaging
Aura GT
Optimized for gene therapy applications, Aura GT maximizes what you can learn about your particles while minimizing the amount of sample you need to analyze.
Features
- Ultra low volume requirement - 5 µL
- Specialized in viral vector stability analysis
- Fluorescence enabled for protein and nucleic acid analysis
- Gene therapy specific assays and workflows
